Literature DB >> 10467266

Regional heterogeneity of the astroglial immunoreactive phenotype: effect of lipopolysaccharide.

E Morga1, C Faber, P Heuschling.   

Abstract

In order to find out whether the concept of regional heterogeneity in astrocytes also applies to the immunoreactive phenotype, we studied cultured primary rat astrocytes originating from five different brain regions (cortex, hippocampus, striatum, septum, and brainstem).We investigated this heterogeneity through the ability of lipopolysaccharide (LPS) to differentially induce several parameters that are known to characterize activated astroglia: major histocompatibility complex (MHC) class II and intercellular adhesion molecule (ICAM)-1 expression, nitric oxide (NO) production, synthesis of interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). Under basal conditions, some of these parameters are already heterogeneic. The presence of LPS enhances these differences: expression of MHC class II increases after a 48-hour incubation with LPS, with brainstem and hippocampus astrocytes reaching the highest levels; NO production is induced by an LPS incubation, with the brainstem showing low NO production levels; septum and striatum instead show higher cytokine (TNF-alpha, IL-6) productions. The baseline expression of ICAM-1 also shows major regional differences, with the brainstem displaying the highest ICAM-1 expression. Our results demonstrate that the immunoreactive abilities of astrocytes show regional heterogeneities. This specialization may be implicated in the pathophysiological pathways of several neurodegenerative disorders. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467266

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

2.  Estrogen actions on neuroendocrine glia.

Authors:  Paul Micevych; Galyna Bondar; John Kuo
Journal:  Neuroendocrinology       Date:  2010-03-24       Impact factor: 4.914

3.  Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS.

Authors:  Jason G Emsley; Jeffrey D Macklis
Journal:  Neuron Glia Biol       Date:  2006-08

4.  TGF beta 1 and TNF alpha potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2.

Authors:  Mary E Hamby; Ariel R Gragnolati; Sandra J Hewett; James A Hewett
Journal:  Neurochem Int       Date:  2007-10-18       Impact factor: 3.921

5.  TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner.

Authors:  Mary E Hamby; James A Hewett; Sandra J Hewett
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-12-08       Impact factor: 3.072

6.  Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection.

Authors:  Brian P Daniels; Harsha Jujjavarapu; Douglas M Durrant; Jessica L Williams; Richard R Green; James P White; Helen M Lazear; Michael Gale; Michael S Diamond; Robyn S Klein
Journal:  J Clin Invest       Date:  2017-01-30       Impact factor: 14.808

7.  Heterogeneity of aquaporin-4 localization and expression after focal cerebral ischemia underlies differences in white versus grey matter swelling.

Authors:  Jesse A Stokum; Rupal I Mehta; Svetlana Ivanova; Edward Yu; Volodymyr Gerzanich; J Marc Simard
Journal:  Acta Neuropathol Commun       Date:  2015-09-30       Impact factor: 7.801

8.  Thymic stromal lymphopoietin is expressed in the intact central nervous system and upregulated in the myelin-degenerative central nervous system.

Authors:  Maja Kitic; Isabella Wimmer; Milena Adzemovic; Nikolaus Kögl; Antonia Rudel; Hans Lassmann; Monika Bradl
Journal:  Glia       Date:  2014-03-25       Impact factor: 7.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.